期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
基于真实世界数据评价罗沙司他治疗维持性透析肾性贫血患者的有效性和安全性 被引量:2
1
作者 龚卫卫 朱龙驯 +3 位作者 陈向凡 陈霞 丰攀峰 唐莲 《药物流行病学杂志》 CAS 2023年第8期849-855,共7页
目的比较罗沙司他与促红细胞生成素(EPO)治疗维持性透析肾性贫血患者的临床疗效与安全性。方法采用前瞻性队列研究设计,选取2020年12月—2021年12月就诊于南通市第一人民医院肾内科使用罗沙司他或EPO治疗的肾性贫血伴或不伴慢性心功能... 目的比较罗沙司他与促红细胞生成素(EPO)治疗维持性透析肾性贫血患者的临床疗效与安全性。方法采用前瞻性队列研究设计,选取2020年12月—2021年12月就诊于南通市第一人民医院肾内科使用罗沙司他或EPO治疗的肾性贫血伴或不伴慢性心功能不全的维持性透析患者,比较肾性贫血患者使用罗沙司他或EPO治疗1个月、3个月及6个月后血红蛋白(Hb)、血清铁蛋白(SF)水平,及用药6个月患者心血管系统不良反应发生情况。结果共纳入142例患者,其中罗沙司他组75例,EPO组67例。两组患者基线期年龄、性别、体重、透析方式与持续时间、既往EPO用量、Hb水平、SF水平、转铁蛋白饱和度、心功能分级及血压水平差异均无统计学意义(P>0.05)。治疗1个月、3个月和6个月后,两组患者的Hb水平均较基线期升高(P<0.05);且治疗1个月后,罗沙司他组Hb水平明显高于EPO组(P<0.05),而治疗3个月、6个月后,两组的Hb水平差异无统计学意义(P>0.05)。治疗后,两组的SF水平、心脑血管系统不良反应发生率等指标差异均无统计学意义(P>0.05)。结论与EPO相比,罗沙司他在初始治疗阶段更具优势,可快速升高Hb水平。罗沙司他与EPO的心血管安全性相当。 展开更多
关键词 罗沙司他 促红细胞生成素 肾性贫血 维持性透析 有效性 心血管安全性 真实世界研究
下载PDF
Cancer incidence and mortality in Zhejiang Province,Southeast China,2016:a population-based study 被引量:24
2
作者 You-Qing Wang Hui-Zhang Li +5 位作者 wei-wei gong Yao-Yao Chen Chen Zhu Le Wang Jie-Ming Zhong Ling-Bin Du 《Chinese Medical Journal》 SCIE CAS CSCD 2021年第16期1959-1966,共8页
Backgrounds:Cancer is one of the main causes of death worldwide,seriously threatening human health and life expectancy.We aimed to analyze the cancer incidence and mortality rates during 2016 in Zhejiang Province,Sout... Backgrounds:Cancer is one of the main causes of death worldwide,seriously threatening human health and life expectancy.We aimed to analyze the cancer incidence and mortality rates during 2016 in Zhejiang Province,Southeast China.Methods:Data were collected from 14 population-based cancer registries across Zhejiang Province of China.Cancer incidence and mortality rates stratified by sex and region were analyzed.The crude rate,age-standardized rate,age-specific and region-specific rate,and cumulative rate were calculated.The proportions of 10 common cancers in different groups and the incidence and mortality rates of the top five cancers in different age groups were also calculated.The Chinese national census of 2000 and the world Segi population was used for calculating the age-standardized incidence and mortality rates.Results:The 14 cancer registries covered a population of 14,250,844 individuals,accounting for 29.13%of the population of Zhejiang Province.The total reported cancer cases and deathswere 55,835 and 27,013,respectively.The proportion ofmorphological verification(MV%)was 78.95%of the population,and percentage of incident cases identified through death certificates only(DCO%)was 1.23%with a mortality-to-incidence ratio(M/I ratio)of 0.48.The crude incidence rate in Zhejiang cancer registration areas was 391.80/105;the age-standardized incidence rate of the Chinese standard population(ASIRC)and the age-standardized incidence rate of theworld standard population(ASIRW)were 229.76/105 and 220.96/105,respectively.The incidence rate in men was higher than that inwomen.The incidence rate increased rapidly after 45 years of age and peaked in individuals aged 80 to 84 years.The top 10 incidence rates of cancers were lung cancer,female breast cancer,thyroid cancer,colorectal cancer,stomach cancer,liver cancer,prostate cancer,cervical cancer,esophageal cancer,and pancreatic cancer(from highest to lowest).The crude mortality rate in Zhejiang cancer registration areas was 189.55/105;the age-standardized mortality rate of the Chinese standard population(ASMRC)and the agestandardized mortality rate of the world standard population(ASMRW)were 94.46/105 and 93.42/105,respectively.The mortality rate in men was higher than that in women,and the male population in rural areas was higher than that in urban areas.The cancer mortality rate increased rapidly after 50 years of age and peaked in individuals aged 85+years.The top 10 mortality rates of cancers were lung cancer,liver cancer,stomach cancer,colorectal cancer,pancreatic cancer,esophageal cancer,female breast cancer,prostate cancer,lymphoma,and leukemia(from highest to lowest).Conclusions:Lung cancer,female breast cancer,thyroid cancer,colorectal cancer,prostate cancer,liver cancer,and stomach cancer were the most common cancers in Zhejiang Province.Effective prevention and control measures should be established after considering the different characteristics of cancers in urban and rural areas. 展开更多
关键词 Cancer registration INCIDENCE Malignant tumor MORTALITY Death certificates Zhejiang Province
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部